Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$63.98 - $85.37 $258,799 - $345,321
-4,045 Reduced 53.41%
3,528 $258,000
Q3 2022

Nov 14, 2022

BUY
$67.99 - $89.57 $12,510 - $16,480
184 Added 2.49%
7,573 $575,000
Q2 2022

Aug 09, 2022

BUY
$56.6 - $89.9 $51,958 - $82,528
918 Added 14.19%
7,389 $514,000
Q1 2022

May 16, 2022

BUY
$60.15 - $84.52 $389,230 - $546,928
6,471 New
6,471 $536,000
Q3 2021

Nov 09, 2021

SELL
$116.17 - $194.55 $538,680 - $902,128
-4,637 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$130.4 - $225.58 $604,664 - $1.05 Million
4,637 New
4,637 $1.03 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.23B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.